As medicine access experts, we keep our finger on the pulse of a fast-moving environment.

We have created this space as a touchstone through which you can keep up to date with the latest access activity and insights.

Optimizing Commercial Launch for Orphan Drugs With Expanded Access Programs

Zogenix Launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution

The Expanded Access Program (EAP) Playbook

Benefits, Challenges and Practicalities of Collecting Real-World Data During Expanded Access Programs

The Real Value of Mapping the Expanded Access Program (EAP) Ecosystem

3 Key Steps to bring EAPs to a Global Market

Evaluating the Cost Impact of an Expanded Access Program

SIFI and Durbin Announce the Opening of an Early Access Program for Akantior the Treatment of Acanthamoeba Keratitis

Cross-Border Expanded Access Programs: Reducing Barriers to Treatment Access